Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Go back to Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
(NASDAQ: ELDN) Delayed: 2.94 -0.08 (2.65%)
Previous Close $3.02    52 Week High
Open $3.02    52 Week Low
Day High $3.03    P/E N/A 
Day Low $2.91    EPS
Volume 827,929